A novel MPL point mutation resulting in thrombopoietin-independent activation
- 31 July 2002
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 16 (8) , 1500-1506
- https://doi.org/10.1038/sj.leu.2402554
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Thrombopoietin-induced conformational change in p53 lies downstream of the p44/p42 mitogen activated protein kinase cascade in the human growth factor-dependent cell line M07eOncogene, 1999
- Control of Thrombopoietin-Induced Megakaryocytic Differentiation by the Mitogen-Activated Protein Kinase PathwayMolecular and Cellular Biology, 1997
- Thrombopoietin induces activation of the phosphatidylinositol-3′ kinase pathway and formation of a complex containing p85PI3K and the protooncoprotein p120CBLJournal of Cellular Physiology, 1997
- Dissecting the thrombopoietin receptor: Functional elements of the Mpl cytoplasmic domainProceedings of the National Academy of Sciences, 1997
- Protein Kinase C andc-mycGene Activation Pathways in Thrombopoietin Signal TransductionBiochemical and Biophysical Research Communications, 1997
- TPO/c-mpl Ligand Induces Tyrosine Phosphorylation of Multiple Cellular Proteins Including Proto-oncogene Products, Vav and c-Cbl, and Ras Signaling MoleculesBiochemical and Biophysical Research Communications, 1995
- Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development.Proceedings of the National Academy of Sciences, 1995
- The c-Mpl Ligand (Thrombopoietin) Stimulates Tyrosine Phosphorylation of Jak2, Shc, and c-MplPublished by Elsevier ,1995
- Control of thrombocytopoiesis: Current state of the artPublished by Springer Nature ,1995
- Thrombocytopenia in c-mpl-deficient miceScience, 1994